BAY1217389 |
Inhibitor of TTK
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TTK |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - PDGFRβ <10 nmol/L
Selectivity Assessment Description:
BAY 1217389 was tested against the DiscoveRx kinase panel (395 kinases) and was found to bind to ...
Potency Cellular
In Vitro
TTK
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
Mouse, Rat, Dog
Dose: 0.5, 1, 2, 4, 8 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
4.1 (M), 7.8 (R), 13 (D) h IV
Systemic clearance:
0.82 (M), 0.54 (R), 0.44 (D) L/h/Kg IV
Reference: --
Chemical Information
| Molecular Formula | C27H24F5N5O3 |
| SMILEs | COc1ccc(Oc2cc(NCCC(F)(F)F)c3ncc(-c4ccc(C(=O)NC5CC5)c(C)c4)n3n2)c(F)c1F |
| InChI | InChI=1S/C27H24F5N5O3/c1-14-11-15(3-6-17(14)26(38)35-16-4-5-16)19-13-34-25-18(33-10-9-27(30,31)32)12-22(36-37(19)25)40-21-8-7-20(39-2)23(28)24(21)29/h3,6-8,11-13,16,33H,4-5,9-10H2,1-2H3,(H,35,38) |
| Molecular weight | 561.18 Da |
| AlogP | 6.040320000000004 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 64 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.